Peter Lee, Analyst, joined Casdin Capital in 2018 and focuses on life science tools, diagnostics, healthcare information technology and services, and industrial applications of biotechnology. Prior to joining Casdin, Peter was on the healthcare investment banking teams at RBC Capital Markets and Canaccord Genuity. Peter holds a B.A. from the University of Chicago and also completed the Postbaccalaureate Premedical Program at Columbia University.